Thromboembolism in Infants and Children With Gastrointestinal Failure Receiving Long-Term Parenteral Nutrition

Abstract

Thromboembolism is an established complication of long-term parenteral nutrition (PN) administration which requires central venous lines in the pediatric population. Predisposing factors that increase the risk of thrombosis, as well as prophylaxis and treatment guidelines in this specific population, are not clearly defined. We performed a computerized search of PubMed, OVID databases, and pertinent articles from reference lists of related review papers. This review summarizes currently available data on the rates of thromboembolism in the pediatric population receiving long-term PN and concludes that control of factors such as location of catheter, duration of nutrition support, and prophylaxis with heparin or anticoagulants may reduce the rates of thrombosis in this patient population, although most data on the matter are inconclusive.

Parenteral nutrition administration for nutrition support in pediatric patients with gastroenteropathies carries with it various complications, including thromboembolism.

Get full access to this article

View all access options for this article.

References

Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology. 2006 ;130(2 Suppl 1):S16– S28.

Tung YC, Ni YH, Lai S, Hseh DY, Chn MH. Clinical improvement following home parenteral nutrition in pediatric patients with intestinal failure. J Formos Med Assoc. 2006 ;105:399– 403.

Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian registry of venous thromboembolic complications. J Pediatr. 1998 ;133:770– 776.

Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood. 1994;83:1251– 1257.

Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995 ;96(5 Pt 1):939– 943.

Kuhle S, Massicotte P, Chan A, et al. Systemic thromboembolism in children: data from the 1–800-NO-CLOTS consultation service.Thromb Haemost. 2004;92:722– 728.

Fonkalsrud EW, Ament ME, Berquist WE, Burke M. Occlusion of the vena cava in infants receiving central venous hyperalimentation. Surg Gynecol Obstet. 1982;154:189– 192.

Swaniker F, Fonkalsrud EW. Superior and inferior vena caval occlusion in infants receiving total parenteral nutrition. Am Surg. 1995;61:877– 881.

Grisoni ER, Mehta SK, Connors AF. Thrombosis and infection complicating central venous catheterization in neonates. J Pediatr Surg. 1986;21:772– 776.

10.

Figa FH, McCrindle BW, Bigras JL, Hamilton RM, Gow RM. Risk factors for venous obstruction in children with transvenous pacing leads.Pacing Clin Electrophysiol. 1997 ;20(8 Pt 1):1902– 1909.

11.

Male C, Chait P, Andrew M, et al. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood. 2003 ;101:4273– 4278.

12.

Imperial J, Bistrian BR, Bothe A Jr, Bern M, Blackburn GL. Limitation of central vein thrombosis in total parenteral nutrition by continuous infusion of low-dose heparin. J Am Coll Nutr. 1983 ;2:63– 73.

13.

Nehme AE, Boyd MC. The impact of total parenteral nutrition on antithrombin III. JPEN J Parenter Enteral Nutr. 1983 ;7:573– 574.

14.

Wakefield A, Cohen Z, Craig M, et al. Thrombogenicity of total parenteral nutrition solutions, I: effect on induction of monocyte/macrophage procoagulant activity. Gastroenterology. 1989 ;97:1210– 1219.

15.

Wakefield A, Cohen Z, Rosenthal A, et al. Thrombogenicity of total parenteral nutrition solutions, II: effect on induction of endothelial cell procoagulant activity. Gastroenterology. 1989 ;97:1220– 1228.

16.

Gauderer MW, Stellato TA. Subclavian broviac catheters in children: technical considerations in 146 consecutive placements. J Pediatr Surg. 1985;20:402– 405.

17.

Andrew M, Marzinotto V, Pencharz P, et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr. 1995 ;126:358– 363.

18.

Dollery CM, Sullivan ID, Bauraind O, Bull C, Milla PJ. Thrombosis and embolism in long-term central venous access for parenteral nutrition.Lancet. 1994;15:1043– 1045.

19.

Marsh D, Wilkerson SA, Cook LN, Pietsch JB. Right atrial thrombus formation screening using two-dimensional echocardiograms in neonates with central venous catheters. Pediatrics. 1988 ;81:284– 286.

20.

Pippus KG, Giacomantonio JM, Gillis DA, Rees EP. Thrombotic complications of saphenous central venous lines. J Pediatr Surg. 1994;29:1218– 1219.

21.

Sadiq HF, Devaskar S, Keenan WJ, Weber TR. Broviac catheterization in low birth weight infants: incidence and treatment of associated complications. Crit Care Med. 1987 ;15:47– 50.

22.

Newall F, Barnes C, Savoia H, Campbell J, Monagle P. Warfarin therapy in children who require long-term total parenteral nutrition.Pediatrics. 2003;112:e386 .

23.

Curnow A, Idowu J, Behrens E, Toomey F, Georgeson K. Urokinase therapy for Silastic catheter-induced intravascular thrombi in infants and children. Arch Surg. 1985 ;120:1237– 1240.

24.

Loeff DS, Matlak ME, Black RE, Overall JC, Dolcourt JL, Johnson DG. Insertion of a small central venous catheter in neonates and young infants.J Pediatr Surg. 1982;17:944– 949.

25.

Schmidt-Sommerfeld E, Snyder G, Rossi TM, Lebenthal E. Catheter-related complications in 35 children and adolescents with gastrointestinal disease on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1990;14:148– 151.

26.

Andrew M, Monagle PBL. Epidemiology of Venous Thromboembolic Events: Thromboembolic Complications during Infancy and Childhood. Hamilton, ON, Canada: B.C. Decker Inc; 2000:124 .

27.

Bertrand M, Presant CA, Klein L, Scott E. Iatrogenic superior vena cava syndrome: a new entity. Cancer. 1984 ;54:376– 378.

28.

Mollitt DL, Golladay ES. Complications of TPN catheter-induced vena caval thrombosis in children less than one year of age. J Pediatr Surg. 1983;18:462– 466.

29.

Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000 ;47:763– 766.

30.

Male C, Chait P, Ginsberg JS, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study: Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost. 2002;87:593– 598.

31.

Male C, Kuhle S, Mitchell L. Diagnosis of venous thromboembolism in children. Semin Thromb Hemost. 2003 ;29:377– 390.

32.

Nowak-Gottl U, Duering C, Kempf-Bielack B, Strater R. Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb. 2003;33:269– 274.

33.

van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr. 2001 ;139:676– 681.

34.

Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the national hospital discharge survey.J Pediatr. 2004;145:563– 565.

35.

Mehta S, Connors AF Jr, Danish EH, Grisoni E. Incidence of thrombosis during central venous catheterization of newborns: a prospective study. J Pediatr Surg. 1992 ;27:18– 22.

36.

Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995 ;74:415– 425.

37.

Kuhle S, Male C, Mitchell L. Developmental hemostasis: pro- and anticoagulant systems during childhood. Semin Thromb Hemost. 2003 ;29:329– 338.

38.

Male C, Julian JA, Massicotte P, Gent M, Mitchell L; PROTEKT Study Group. Significant association with location of central venous line placement and risk of venous thrombosis in children. Thromb Haemost. 2005 ;94:516– 521.

39.

Casado-Flores J, Barja J, Martino R, Serrano A, Valdivielso A. Complications of central venous catheterization in critically ill children.Pediatr Crit Care Med. 2001 ;2:57– 62.

40.

Craft PS, May J, Dorigo A, Hoy C, Plant A. Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. AustNZJ Med. 1996 ;26:33– 39.

41.

De Cicco M, Matovic M, Balestreri L, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term Silastic catheter: a prospective study. Thromb Res. 1997 ;86:101– 113.

42.

Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest. 1998 ;114:207– 213.

43.

Trerotola SO, Kuhn-Fulton J, Johnson MS, Shah H, Ambrosius WT, Kneebone PH. Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access.Radiology. 2000;217:89– 93.

44.

Farber SP, O'Donnell TF Jr, Deterling RA, Millan VG, Callow AD. The clinical implications of acute thrombosis of the inferior vena cava.Surg Gynecol Obstet. 1984 ;158:141– 144.

45.

Bern MM, Bothe A Jr, Bistrian B, Champagne CD, Keane MS, Blackburn GL. Prophylaxis against central vein thrombosis with low-dose warfarin.Surgery. 1986;99:216– 221.

46.

Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med. 1990 ;112:423– 428.

47.

Barnes C, Newall F, Ignjatovic V, et al. Reduced bone density in children on long-term warfarin. Pediatr Res. 2005 ;57:578– 581.

48.

Yeung CY, Lee HC, Huang FY, Wang CS. Sepsis during total parenteral nutrition: exploration of risk factors and determination of the effectiveness of peripherally inserted central venous catheters. Pediatr Infect Dis J. 1998;17:135– 142.

49.

Kurkchubasche AG, Smith SD, Rowe MI. Catheter sepsis in short-bowel syndrome. Arch Surg. 1992 ;127:21– 25.

50.

Nousia-Arvanitakis S, Angelopoulou-Sakadami N, Metroliou K. Complications associated with total parenteral nutrition in infants with short bowel syndrome. Hepatogastroenterology. 1992 ;39:169– 172.

51.

Moukarzel AA, Haddad I, Ament ME, et al. 230 Patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg. 1994 ;29:1323– 1327.

52.

Hodge D, Puntis JW. Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition.Arch Dis Child Fetal Neonatal Ed. 2002 ;87:F21– F24.

53.

Terra RM, Plopper C, Waitzberg DL, et al. Remaining small bowel length: association with catheter sepsis in patients receiving home total parenteral nutrition: evidence of bacterial translocation. World J Surg. 2000;24:1537– 1541.

54.

O'Keefe SJ, Burnes JU, Thompson RL. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. JPEN J Parenter Enteral Nutr. 1994;18:256– 263.

55.

Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children.Intensive Care Med. 2000 ;26:967– 972.

56.

Kalmanti M, Germanakis J, Stiakaki E, et al. Prophylaxis with urokinase in pediatric oncology patients with central venous catheters.Pediatr Hematol Oncol. 2002 ;19:173– 179.

57.

Dillon PW, Jones GR, Bagnall-Reeb HA, et al. Prophylactic urokinase in the management of long-term venous access devices in children: a children's oncology group study. J Clin Oncol. 2004 ;22:2718– 2723.

58.

La Quaglia MP, Caldwell C, Lucas A, et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Pediatr Surg. 1994 ;29:742– 745.